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Aim To determine whether higher glucose level and sys-
temic oxidative stress decrease mean velocity (MV) index 
of the central retinal artery (CRA) during flickering light 
stimulation in type 1 diabetes (T1D).
Methods The study was performed in the period from 
2008 to 2015 at the University Eye Clinic in Ljubljana. 41 pa-
tients with T1D and 37 participants without diabetes were 
included. MV in the CRA was measured using Doppler ul-
trasound diagnostics in basal conditions and during 8 Hz 
flickering light irritation. The plasma levels of glucose, fruc-
tosamine, 8-hydroxy-2’-deoxyguanosine (8-OHdG), triglyc-
erides, cholesterol, and low-density lipoprotein (LDL) were 
measured.
Results Patients with T1D had significantly higher levels 
of blood glucose (P < 0.001), fructosamine (P < 0.001), and 
8-OHdG (P < 0.001), but there were no significant differences 
in triglycerides (P = 0.108), cholesterol (P = 0.531), and LDL 
(P = 0.645) between the groups. Patients with T1D also 
had a significantly lower MV index in the CRA (1.11 ± 0.15 
vs 1.24 ± 0.23; P = 0.010). In the T1D group, a significant 
negative correlation was found between the level of 
glucose (r = −0.58; P < 0.001), fructosamine (r = −0.46; 
P = 0.003), 8-OHdG (r = −0.48; P = 0.002) and the MV index 
in the CRA. At the same time, in this group fructosamine 
and 8-OHdG levels had a separate effect on the MV index 
(adjusted R2 = 0.38, P < 0.001).
Conclusion Higher glucose levels, the medium-term glu-
cose level, and systemic oxidative stress could importantly 
reduce retinal vasodilatation during flickering light irrita-
tion in patients with T1D.
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Metabolic changes caused by hyperglycemia in type 1 dia-
betes (T1D) affect retinal cells’ function, resulting in func-
tional disturbances in the vessels during the increased 
metabolic load of the retina (1). Before changes are de-
tected in the function of ganglion cells, there are malfunc-
tions in neurovascular coupling, with modified vascular au-
toregulation in the retina (2). There are various diagnostic 
methods available to measure the extent of vasodilatation 
disability (3-5). Retinal irritation with flickering light causes 
increased metabolic activity, particularly in the ganglion 
retinal cells, with subsequent vasodilation of the local ves-
sels and an increased blood flow. In this regard, an impor-
tant role is played by vasodilators such as nitric oxide, as 
well as derivatives of arachidonic acid. The impact of some 
metabolites, such as lactate and adenosine diphosphate, 
was also identified (6,7). The vasoactive molecules are re-
leased directly from the nerve cells and neuroglia as well 
as the endothelial cells in the vessel walls (6,7).
Studies so far have discovered negative correlations be-
tween the retinal arterial dilatation during flickering light 
stimulation and blood glucose level 2 hours after oral glu-
cose ingestion in patients with T1D (8) and in a healthy 
group (5). Retinal venous dilation in similar conditions was 
negatively correlated with glycated hemoglobin in pa-
tients with diabetes in one study (9), but another study did 
not show the same findings (8). The correlations between 
retinal vessel dysfunction and other systemic biochemical 
factors have not been investigated so far. Therefore, the 
aim of our study was to determine whether higher glu-
cose and medium-term (1-2 weeks) glucose plasma level 
indicated by fructosamine, higher systemic oxidative stress 
indicated by 8-hydroxy-2’-deoxyguanosine (8-OHdG), and 
higher levels of triglyceride, cholesterol, and lipoproteins 
decrease mean velocity (MV) index of central retinal artery 
(CRA) in patients with T1D.
PAtientS AnD MethODS
The study was carried out from July 2008 to January 2015 
at the University Eye Hospital of the University Medical 
Centre in Ljubljana. All eligible patients with previously 
diagnosed T1D were participants in the diabetic retinal 
screening program at the outpatient department of the 
hospital. The patient group was randomly selected from a 
larger group of patients using random number generator. 
Healthy hospital employees were selected for the control 
group by the same technique from the list of employees 
taking into account approximately the same age and sex 
ratio compared to the patient group. The participants were 
invited to take part in the study and informed of the pur-
pose and side effects of the research, and signed the in-
formed consent form. Ethical approval was received from 
the Medical Ethics Committee of the Republic of Slovenia 
in the document number 38/02/07. To begin, a test sample 
size of 20 participants was assembled and the final size of 
both groups was determined by power and sample-size 
analysis for a two-sample means test. We needed a total 
number of 80 participants divided into two equal groups 
to detect the significant mean difference of the MV indi-
ces. The study involved 78 participants, who were divid-
ed into two approximately equal groups. Patient group 
comprised 41 patients with T1D and the control group 
comprised 37 participants without diabetes. By selecting 
patients with T1D, we avoided the effect of insulin resist-
ance in type 2 diabetes (T2D), which could further affect 
the function of the vascular system. Also, patients with T2D 
more frequently suffer from obesity, arterial hypertension, 
hypertriglyceridemia, or lower high-density lipoprotein 
(HDL) levels (10), which might further affect the study re-
sults. In order to exclude the effect of age, the participants 
in both groups were of the same age (32.6 ± 6.7 years in 
the T1D group and 30.3 ± 5.1 years in the control group; 
P = 0.102). All the participants with untreated hypertension 
and a blood pressure of 140/90 mm Hg or more were not 
included in the study. Blood pressure was measured on the 
upper arm using a pressure monitor while the participants 
were sitting in an upright position. Individuals with a body 
mass index of more than 30 were also not included.
All the participants underwent an ophthalmologic exami-
nation of the anterior and posterior segments of the eye 
using a slit lamp, and the clinical documentation of patients 
with T1D was reviewed. The visual acuity with optical cor-
rection of all the participants was measured using a Snellen 
chart, and individuals with a VA of less than 20/25 were not 
included. Patients with T1D and any sign of diabetic retin-
opathy were also not included, as well as individuals with 
opaque optical media in the cornea, anterior segment, in-
traocular lens, and the vitreous body, and other retinal dis-
eases (hypertensive retinopathy, occlusion of retinal vessels, 
etc). IOP was measured using Goldmann applanation to-
nometry. All patients with glaucoma and participants with 
an IOP of over 21 mm Hg were not included.
Measuring the MV in the CRA using a Doppler 
ultrasound device
The MV was measured using the ATL HDI 1000 Ultra-
sound System (ATL Ultrasound Inc., Bothell, WA, 
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USA), a Doppler ultrasound device, with a linear transducer 
11-5 L. All the measurements were made from 09.00 am to 
11:59 am by one person in a darkened room. Participants 
were allowed to have a five-minute rest period before the 
measurement and were lying in a horizontal position. The 
ultrasonic transducer was used to measure the MV in the 
CRA, just behind the eye in the optic nerve, through the 
upper eyelid with a fixed eye view at a 45-degree angle. 
In the first phase, three measurements were made in basal 
conditions, without light irritation, at five-minute intervals. 
In the second phase, the eyeball was exposed to 45 sec-
onds of 8 Hz halogen lamp flickering light stimulation with 
a MV measurement made at the end of the irritation. Two 
similar measurements were repeated during five-minute 
intervals. The Pulsed-Wave Doppler Mode was used for a 
hemodynamic assessment of the MV in the CRA. The MV 
index is calculated from the ratio of two measurements:
The measurements of the MV in the CRA in basal conditions 
were carried out by one person using a Doppler ultrasound 
device on 12 healthy participants in order to assess their re-
peatability. The measurements were carried out three times 
in three sessions, with one week between them.
Biochemical analysis
Venous blood was taken from the cubital vein of the fasted 
participants, without using any additives, between 08.00 
am and 09.00 am All the biochemical investigations were 
carried out at the Institute of Clinical Chemistry and Bio-
chemistry of the University Medical Centre in Ljubljana. Af-
ter blood centrifugation, the serum was stored at -20°C for 
further analyses. All the investigations were conducted si-
multaneously. Using enzymatic calorimetric methods, we 
determined the level of glucose, triglycerides, and choles-
terol. Fructosamine was measured using the colorimetric 
method. HDL was measured using the direct method. The 
procedure was performed on an ADVIA automated ana-
lyzer (Siemens Diagnostics, Erlangen, Germany). Using the 
Friedewald formula, we determined the level of low-den-
sity lipoprotein (LDL) particles. The level of 8-OHdG in the 
serum was measured using the enzyme-linked immuno-
sorbent assay method (JICA, Shizuoka, Japan).
Statistical analysis
Normally distributed variables are presented as means 
and standard deviations and not-normally distrib-
uted variables are presented as medians and ranges. To 
assess the normality of distribution, we used the Shapiro-
Wilk test. In both groups of participants, levels of choles-
terol, HDL, LDL, and the MV values during the basal con-
ditions were normally distributed. In patients with T1D, 
unlike the control group, fructosamine level and the MV 
index were normally distributed. In both groups, the lev-
els of glucose, 8-OHdG and triglycerides, and the MV value 
during flickering light, were not normally distributed. The 
parametric variables were analyzed using an independent 
two-sample t test and the Pearson product moment cor-
relation coefficient. For the nonparametric variables, we 
used the Mann-Whitney U-Test and the Spearman rank 
correlation coefficient test. Multiple linear regression was 
used to determine the influence of independent prog-
nostic variables. We estimated the reproducibility of the 
measurements using the coefficient of variation. P values 
<0.05 were considered statistically significant. All statisti-
cal calculations were performed using IBM SPSS Statistics 
v. 20 software (IBM, Armonk, NY, USA).
ReSultS
There were no differences in sex (18 men and 23 women 
in the T1D group vs 16 men and 21 women in the control 
group; P = 0.963) and age between the groups (32.6 ± 6.7 
years and 30.3 ± 5.1 years, respectively; P = 0.102). The pa-
tients had T1D for 18.1 ± 7.9 years. 15 patients had an in-
sulin pump, while the rest were treated with insulin injec-
tions. 5 patients with T1D and only one control participant 
were treated for hypertension before the study, but the 
difference was not significant (P = 0.124). Systolic (SBP)/di-
astolic blood pressure (DBP) was lower than 140/90 mm 
Hg in all participants. There were no significant differences 
between the groups in either SBP (T1D group 117.7 ± 12.7 
mm Hg and controls 119.7 ± 12.4 mm Hg, P = 0.480) or 
DBP (74.2 ± 8.4 mm Hg and 72.2 ± 8.9 mm Hg, respectively, 
P = 0.308). 2 control participants and 8 patients with T1D 
were smokers, but the difference in smoking status be-
tween the groups was not significant (P = 0.063).
The IOP was approximately the same in both groups (15.8 
mm Hg ±3.4 in T1D group vs 15.0 ± 5.4 mm Hg in controls; 
P = 0.424). Patients with T1D had significantly higher aver-
age levels of glucose (P < 0.001), fructosamine (P < 0.001), 
and 8-OHdG (P < 0.001). However, there were no signifi-
cant differences in the levels of triglycerides, cholesterol, 
LDL, and HDL (Table 1). 58.5% of patients with T1D and 
5.4% of controls had fasting glucose level higher than 6.1 
mmol/L.
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In patients with T1D, there were significant positive cor-
relations between the level of glucose and fructosamine 
(r = 0.80; P < 0.001) and the level of glucose and 8-OHdG 
(r = 0.45; P = 0.003). Similarly, in the control group there was 
a positive correlation between the level of glucose and 
fructosamine (r = 0.51; P = 0.001) but there was no corre-
lation between the level of glucose and 8-OHdG (r = 0.23; 
P = 0.143). Multiple linear regression showed that fructos-
amine and 8-OHdG levels had a separate effect on the MV 
index in patients with T1D. The regression model explained 
the greatest proportion of the variability of the MV index 
(R2 of the model = 0.38; P < 0.001) (Table 2).
Patients with T1D had significantly lower average MV in 
the CRA in basal conditions (P = 0.019) and during flicker-
ing light stimulation (P < 0.001). The MV index was also sig-
nificantly lower in that group (P = 0.010) (Table 3).
The repeatability of the three measurements was tested on 
12 participants. The coefficient of the variation, or repeat-
ability, of measurements of the MV was 5.6%. The correla-
tion coefficient between the measurements of this param-
eter by the same investigator was 0.89 (P < 0.001).
tABle 2. Model of multiple linear regression for analyzing the influence of different independent variables on the mean velocity 
index in patients with type 1 diabetes*
Variable b P R2 of the sequence R2 of the model
8-hydroxy-2’-deoxyguanosine −0.0047 <0.001 0.28 0.38
Fructosamine −0.00048  0.013 0.38 P < 0.001
*b − regression coefficient; R2 − coefficient of determination.
tABle 3. the mean velocity (MV) in the central retinal artery and the MV index in patients with type 1 diabetes and the control group*
Variable type 1 diabetes (n = 41) Control group (n = 37) P
MV in basal conditions (cm/s) 6.44 ± 1.70 7.44 ± 1.99  0.019
MV during flickering light (cm/s) 6.8 (5.83-7.75) 9.10 (7.41-10.56) <0.001†
MV index 1.11 ± 0.15 1.17 (1.08- 1.36)  0.010†
*Mean ± standard deviation for normally and median (interquartile range) for not-normally distributed variables.
†Mann-Whitney u-test; unmarked independent two-sample t test.
tABle 1. Biochemical analyses in patients with type 1 diabetes and control group
Variable type 1 diabetes (n = 41) Control group (n = 37) P
Glucose (mmol/L)   7.3 (4.4-8.6)*   4.0 (3.3-4.5) <0.001†
Fructosamine (mg/L) 392 ± 103 217 (189-252) <0.001†
8-hydroxy-2’-deoxyguanosine (µg/L)  28.08 (22.13-35.82)  12.43 (6.35- 22.25) <0.001†
Cholesterol (mmol/L)   4.7 ± 0.7   4.8 ± 0.9  0.531
High density lipoproteins (mmol/L)   1.4 ± 0.3   1.4 ± 0.3  0.793
Low density lipoproteins (mmol/L)   2.7 ± 0.7   2.6 ± 0.7  0.645
Triglyceride (mmol/L)   0.9 (0.7-1.1)   1.0 (0.8-1.3)  0.108†
*Mean ± standard deviation for normally and median (interquartile range) for not-normally distributed variables.
†Mann-Whitney u-test; unmarked independent two-sample t test.
tABle 4. Correlation between mean velocity index and clinical 
or biochemical variables in patients with type 1 diabetes and 
the control group*




Variable r P r P
Age   0.045 0.781   0.0081† 0.962
Diabetes duration   0.17 0.294
SBP −0.092 0.572   0.0017† 0.995
DBP   0.15 0.362   0.11† 0.514
IOP   0.27 0.083 −0.14† 0.408
Glucose −0.58† <0.001   0.23† 0.166
Fructosamine −0.46 0.003   0.33† 0.045
8-OHdG −0.48† 0.002   0.18† 0.276
Cholesterol −0.12 0.471   0.40† 0.014
HDL −0.10 0.521   0.29† 0.087
LDL   0.00010 0.984   0.14† 0.403
Triglyceride −0.16† 0.315 −0.18† 0.293
*SBP – systolic blood pressure; DBP – diastolic blood pressure; iOP 
– intraocular pressure; 8-OhdG – 8-hydroxy-2’-deoxyguanosine; 
hDl – high density lipoproteins; lDl – low density lipoproteins; r – 
coefficient of correlation.
†Spearman rank correlation coefficient; unmarked Pearson product 
moment correlation coefficient.
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In patients with T1D, a significant negative correlation was 
found between the MV index and the level of glucose 
(r = −0.58; P < 0.001), fructosamine (r = −0.46; P = 0.003), and 
8-OHdG (r = −0.48; P = 0.002). In the control group, there 
was a comparable significant positive correlation between 
the MV index and the fructosamine level. In patients with 
T1D, there was no significant correlation between partici-
pants’ age, duration of diabetes, SBP, DBP, IOP, cholesterol 
levels, HDL, LDL, and triglycerides with the MV index (Table 
4 and Figures 1 and 2).
DiSCuSSiOn
Using a Doppler ultrasound examination on Pulsed-Wave 
Doppler Mode, we observed lower ability of retinal va-
soregulation during increased retinal metabolic load in pa-
tients with T1D. Similar results using the same technique 
have not been published in diabetic patients recently but 
lower retinal vasodilation in similar conditions was found 
using another technique (Dynamic Vessel Analyzer) (11,12). 
Our results indicate that diabetes has a significant impact 
on the reduction of vasodilatation during increased retinal 
metabolism due to flickering light stimulation. Neurode-
generative changes in the retina occur early in the course 
of diabetes and affect neurovascular coupling. In particu-
lar, there are interferences in the release of the vasodilators 
when metabolic requirements are high (6,13,14). Direct 
vascular failure in diabetes takes place only afterwards (2).
An ultrasound examination using the Pulsed-Wave Dop-
pler Mode provides a high degree of precision, with ap-
propriate reproducibility, for measuring blood velocity in 
the orbital vessels and corresponds to the intra-subject re-
producibility of our measurements of the MV in the CRA 
(15,16). Taking these results into account, we can conclude 
that the method is reliable for measuring the blood flow in 
the CRA and that it can be used for further investigations.
In appropriately controlled and treated patients with dia-
betes, the fasting glucose level in the morning should be 
in the normal range. In insulin-treated patients with T1D 
we found higher plasma glucose level than in controls, and 
in more than half of the patients it was above the upper 
limit of the normal range. The majority of our patients had 
FiGuRe 1. Correlation between the level of glucose/fructosamine and the mean velocity (MV) index in the central retinal artery (CRA) 
in patients with type 1 diabetes; r – coefficient of correlation.
FiGuRe 2. Correlation between 8-hydroxy-2’-deoxyguanosine 
level and the mean velocity (MV) index in the central retinal 
artery (CRA) in patients with type 1 diabetes; r – coefficient of 
correlation.
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poor glycemic control. Patients with T1D with hyperglyc-
emia 1 and 2 h after glucose ingestion and no clinical signs 
of diabetic retinopathy had a significantly lower retinal va-
sodilatation ability during flickering light stimulation when 
measured by the Retinal Vessel Analyzer but after normali-
zation of hyperglycemia, the vasodilatation ability quick-
ly returned to normal (8). Using the same measuring and 
stimulation technique, an increased blood glucose level 
in healthy people was found to have a negative effect on 
retinal vasodilatation (5). When Doppler ultrasound device 
was used in our study, a negative correlation was recorded 
between the glucose level and the MV index in the CRA 
in patients with T1D. There was evidence of the impact of 
blood glucose on retinal blood vessel dysfunction. Hyper-
glycemia instigates biochemical changes that play an im-
portant role in the development of retinal neuronal and 
vascular dysfunction (17).
Fructosamines result from the glycation of serum proteins 
and reflect the mean blood glucose levels for the previous 
two to three weeks, which can be used as clinical indica-
tors of recent changes in glycemic control (18). The link be-
tween the glycated hemoglobin level and retinal vasodila-
tation ability during flickering light stimulation is described 
in the literature, but no reference is made to the links with 
fructosamine (8,19). We revealed for the first time a signifi-
cant negative correlation between fructosamine level and 
the MV index in the CRA during retinal flickering light irrita-
tion in patients with T1D. This result confirms that the im-
pact of the higher medium-term glucose level in patients 
with T1D also has as important an effect on retinal vasodil-
atation as the current blood glucose level.
8-OHdG levels in patients with diabetes are higher than 
in control participants, not only in the blood but also in 
the urine and vitreous body (20,21). As was expected, we 
found a similar difference in the plasma 8-OHdG levels. 
8-OHdG is an indicator of oxidative stress and is formed by 
oxidation of the deoxyguanosine in the DNA in the nucle-
us and mitochondria. Increasing amounts of ROS are found 
in the serum of diabetic patients, especially in those with 
poor glycemic control. The relative increase in oxidative 
metabolites contributes to the damage of retinal vessels 
(22). Damage to mitochondrial DNA has a negative impact 
on the metabolism and leads to a dysfunction, particular-
ly of the ganglion and retinal vascular cells (2). The influ-
ence of an oxidative stress marker or ROS component on 
retinal vasodilatation ability due to flickering light stimula-
tion in patients with diabetes is not described in the litera-
ture. In the T1D group, we found an inverse relationship 
between the 8-OHdG level and the MV index in the CRA 
during flickering light stimulation owing to the increased 
metabolic load. Due to the positive interdependence be-
tween the level of glucose and 8-OHdG, the question arose 
as to whether increased oxidative stress might be a direct 
cause of worsened vasodilatation or simply a by-product 
of glucose metabolism. We found a statistically independ-
ent effect of 8-OHdG level on this index in patients with 
T1D. These findings indicate that higher systemic oxidative 
stress or individual components of ROS in the blood could 
directly affect the malfunction of the retinal vasculature 
during increased metabolic load due to irritation caused 
by flickering light. Oxidative stress is the consequence of 
hyperglycemia, which in turn causes the overproduction 
of ROS in body fluids.
Hypertension and T1D coexist more frequently than usual 
(23), but we did not observe a higher frequency of hyper-
tension in patients with T1D. We also did not find an effect 
of normal blood pressure on the change of the MV index 
in the CRA during flickering light stimulation.
Diabetic patients with a normally controlled disease usu-
ally have normal or suppressed levels of triglycerides and 
LDL particles, while patients with poorly controlled glyc-
emia commonly have elevated triglycerides and LDL lev-
els (24). In this study, both groups had lipid levels within 
normal range, and there were no differences between the 
groups.
The importance of the study is increased by the high re-
producibility of measurements, which is manifested as a 
low coefficient of variation and a high positive correlation 
coefficient between the individual measurements taken 
from a certain number of patients. This method enables 
the rapid detection of dysfunction in morphologically un-
changed retinal vessels. There have not yet been any simi-
lar comparative studies among younger people with T1D.
There are several limitations of this study. We did not meas-
ure the CRA diameter in the optic nerve concomitantly 
with MV. Our result allowed only partial description of the 
retinal hemodynamic properties and it was not possible to 
calculate the blood flow in the retinal vessels. The levels of 
fructosamine and 8-OHdG level in our study were not com-
parable with the results of other studies because these 
measurements were used only for research purposes and 
there are no general reference values for comparison of 
the results. 5 patients with T1D and only 1 man in the 
control group were treated for arterial hypertension 
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before the beginning of the study. Antihypertensive drugs 
and treated arterial hypertension could affect the dysfunc-
tion of the retinal blood vessels during the flickering light 
irritation and the accuracy of measurements of MV in CRA.
The significance of the functional vascular disorder of 
the retina during flickering light stimulation in the forma-
tion and prognosis of diabetic retinal pathology is not yet 
known. Despite the observed connection between sys-
temic oxidative stress and functional vascular disorders 
of the retina, measurement of the 8-OHdG level during 
screening of the patients with T1D has no clinical signifi-
cance. Further studies are required to identify possible 
connections between retinal functional vascular disorders 
and clinically undetectable morphological changes in the 
retina, the probability of occurrence and rate of progres-
sion of diabetic retinopathy, and the possibility of severe 
and proliferative diabetic retinopathy. If these hypotheses 
are accepted, the measurement of retinal functional vascu-
lar disorder, and even more systemic biochemical markers 
associated with it, will play an important role in long-term 
screening of the patients with T1D.
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